You are about to leave the Clinical Value website now.

Cancel

APAC Oncology Summit 2023 Webinar

Endorsed by:
Join us for an insightful webinar discussion on the use of precision oncology and lung cancer management in the Asia-Pacific (APAC) region. This webinar features leading oncologists who will share their clinical expertise and discuss the application of precision oncology and updated lung cancer treatment in APAC region, across 2 consecutive sessions:

Session 1

Timely Diagnosis to Enable Personalized Healthcare with Clinical Decision Support Tools

Time

14:30 - 16:00

Topics

The value of precision oncology, gaps in implementation process, and updates on Taiwan molecular tumour board (MTB) consensus

Overcoming barriers to precision oncology implementation with digital solutions

Updates on comprehensive genomic profiling (CGP) validation and evidence

Session 2

Navigating the Lung Cancer Journey from Early to Advanced

Time

16:15 - 18:50

Topics

Clinical considerations for metastatic ALK+ patients with multiple treatment options

Navigating First-line Therapies in Advanced Non-Squamous NSCLC across a comprehensive treatment journey

Updates on treatment for early-stage lung cancer patients with driver mutation or PD-L1+

Get access to the webinar recordings now by filling in the registration form below!

Sign up now to get access to the webinar recordings


You might want to join us if you are a:

  • Oncologist
  • Pulmonologist
  • Molecular Pathologist
  • Geneticist
  • Digital Expert

Session 1: Timely Diagnosis to Enable Personalized Healthcare with Clinical Decision Support Tools

Key reasons to attend:

  • Learn about current clinical practices and unmet needs in precision oncology in APAC
  • Get updates on the evolution of precision oncology along the patient journey
  • Hear from experts on their clinical experience using CGP, MTB, and digital solutions in clinical settings

Speakers

A/Prof. Herbert Loong

Medical Director, Phase 1 Clinical Trials Centre, The Chinese University of Hong Kong

Prof. Min-Huang Chen

Chief, Center for Immuno-oncology, Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan

Prof. Giuseppe Curigliano

Head of the Division of Early Drug Development, European Institute of Oncology, IRCCS, Italy

Prof. Manop Pithukpakorn

Clinical Geneticist & Molecular Geneticist, Siriraj Hospital, Mahidol University, Bangkok, Thailand

Agenda

Time

Topic

Speakers

14:30 - 14:35
Opening remarks
A/Prof. Herbert Loong
14:35 - 15:00
Value of Precision Oncology and Current Gap in the Implementation Process: Taiwan Oncology Society MTB Consensus Update
Prof. Min-Huang Chen
15:00 - 15:25
Breaking Barriers to Precision Oncology Implementation with Digital Solutions
Prof. Giuseppe Curigliano
15:25 - 15:50
Good Practice Sharing on CGP Validation and Evidence Updates
Prof. Manop Pithukpakorn
15:50 - 16:00
Panel Discussion
All

Session 2: Navigating the Lung Cancer Journey from Early to Advanced

Key reasons to attend:

  • Get up-to-date information on treatment for early-stage lung cancer patients with driver mutation or PD-L1+
  • Explore clinical considerations regarding multiple treatment options for metastatic ALK+ patients
  • Understand the comprehensive treatment journey, from initial strategy to post-EGFR progression, for advanced non-squamous NSCLC

Speakers

Prof. Tony Mok

Chairman, Department of Clinical Oncology, The Chinese University of Hong Kong

Prof. Virote Sriuranpong

Department of Internal Medicine, Faculty of Medicine, Chulalongkorn University, Thailand

Dr. Aaron Tan

Senior Resident Physician, National Cancer Centre Singapore

Prof. Byoung Chul Cho

Chief, Lung Cancer Center, Yonsei Cancer Center, Korea

Agenda

Time

Topic

Speakers

16:15 - 16:30
Opening remarks
Prof. Tony Mok
16:30 - 17:00
Clinical Considerations for Metastatic ALK+ Patients in the Era of Multiple Treatment Options
Prof. Virote Sriuranpong
17:00 - 17:15
Panel Discussion
All
17:15 - 17:45
Navigating First-line Therapies in Advanced Non-Squamous NSCLC: From Initial Strategies to Post-EGFR Progression Challenges
Dr. Aaron Tan
17:45 - 18:00
Panel Discussion
All
18:00 - 18:30
The Evolving Landscape in Early Lung Cancer Management with Systemic Treatment for Driver Mutation and PD-L1+ Patients
Prof. Byoung Chul Cho
18:30 - 18:45
Panel Discussion
All
18:45 - 18:50
Closing
Prof. Tony Mok

Date:

30thNovember 2023

Time:
14:30 - 18:50 (GMT+08:00)
11:30 - 15:50 (Karachi)
12:00 - 16:20 (Delhi)
13:30 - 17:50 (Bangkok / Ho Chi Minh / Jakarta)
14:30 - 18:50 (Hong Kong / Kuala Lumpur / Singapore)
15:30 - 19:50 (Seoul / Tokyo)
16:30 - 20:50 (Melbourne)
18:30 - 22:50 (New Zealand)

This material represents personal viewpoint and is intended to promote the communication and exchange of medical information, and shall be used by healthcare professionals as a reference only. This material may contain medicinal products or clinical indications that have not yet been approved in your country. Please refer to the locally approved package insert for detailed prescription information.

Be the first to receive updates, event opportunities, and thought leadership insights.

The information contained in this website is intended for healthcare professionals only.
Click “OK” if you are a healthcare professional.

OK